Kisunla 350 mg/20 mL (17.5 mg/mL) injection Images
Generic Name: donanemab
This medication has been identified as Kisunla 350 mg/20 mL (17.5 mg/mL) injection. It is supplied by Eli Lilly and Company.
Kisunla is used in the treatment of Alzheimer's Disease and belongs to the drug class miscellaneous central nervous system agents. Kisunla 350 mg/20 mL (17.5 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Kisunla
- Generic Name
- donanemab
- Strength
- 350 mg/20 mL (17.5 mg/mL) injection
- Availability
- Prescription only
- Drug Class
- Miscellaneous central nervous system agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Eli Lilly and Company
- National Drug Code (NDC)
- 00002-9401
See also:
Namenda
Namenda is used to treat dementia associated with Alzheimer's disease. Learn about side effects ...
Exelon
Exelon (rivastigmine) is used to treat dementia caused by Alzheimer's or Parkinson's disease ...
Aricept
Aricept is used to treat mild to severe dementia caused by Alzheimer's disease. Learn about side ...
Leqembi
Leqembi (lecanemab) is used to treat Alzheimer’s disease to help slow the progression of dementia s ...
Namzaric
Namzaric (memantine/donepezil) is used to treat Alzheimer's Disease. Includes Namzaric side ...
Razadyne
Razadyne information from Drugs.com, includes Razadyne side effects, interactions and indications.
Zunveyl
Zunveyl (benzgalantamine) is used to treat mild to moderate dementia in Alzheimer's disease (AD) ...
More about Kisunla (donanemab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous central nervous system agents
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.